Trials / Withdrawn
WithdrawnNCT00846014
Asthma Exacerbation and Helium-3 MRI
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this research is to use Helium-3 MRI to see the changes in airflow of the lungs at different times of an attack. These three stages are immediately after the attack, 1 month later and 4-6 months later.
Detailed description
Asthma is a pulmonary disorder that affects millions of people each year. The exact method of exacerbation is still under some discussion. Currently there is no cure for the disorder but treatment is of a wide variety. This study is meant to image the asthmatic lung at various time points post exacerbation. Since pulmonary imaging is currently limited to radiation techniques, this method will allow exacerbated images without the unnecessary exposure to radiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Helium-3 | Patients will be required to breath in individual 1 liter bags of gas while in an MRI to produce lung images. These bags of gas are each made up of 333mL of Helium-3 gas and 667mL of Nitrogen. The first three bags will be administered with a break between each of five to ten minutes. Then the drug aformoterol will be administered and an hour will pass. Then three additional bags will be administered, again with five to ten minutes between each bag. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2009-02-18
- Last updated
- 2012-09-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00846014. Inclusion in this directory is not an endorsement.